ArticleHeliyon2023

Bevacizumab, a vascular endothelial growth factor inhibitor, promotes orthodontic tooth movement in an experimental rat model.

Hatem Abuohashish et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.